Patricia Carvajal
Biographic Data
| ID | 5207755 |
|---|---|
| NAME | Patricia Carvajal |
| GIVEN NAMES | Patricia |
| FAMILY NAME | Carvajal |
| SIGNATURE | CARVAJAL P |
| AFFILIATIONS | University of Chile |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1984 |
| LATEST PUBLICATION YEAR | 1984 |
| H-INDEX | 1 |
Erythrocyte and HLA antigens of Atacameño Indians
The present study reports the results of erythrocyte antigen typing for the following systems: ABO, MN, Rh, Kell, Duffy, and Diego in roughly 180 Atacameño Indians from the oasis of Toconao, northern Chile. A subsample was tested for variation at the histocompatibility loci A, B, and C. Results agree with previous findings based on smaller samples. Caucasian admixture of the Atacameños from Toconao was estimated to be 0.056 ± 0.022
Erythrocyte and HLA antigens of Atacameño Indians
The present study reports the results of erythrocyte antigen typing for the following systems: ABO, MN, Rh, Kell, Duffy, and Diego in roughly 180 Atacameño Indians from the oasis of Toconao, northern Chile. A subsample was tested for variation at the histocompatibility loci A, B, and C. Results agree with previous findings based on smaller samples. Caucasian admixture of the Atacameños from Toconao was estimated to be 0.056 ± 0.022
Erythrocyte and HLA antigens of Atacameño Indians
The present study reports the results of erythrocyte antigen typing for the following systems: ABO, MN, Rh, Kell, Duffy, and Diego in roughly 180 Atacameño Indians from the oasis of Toconao, northern Chile. A subsample was tested for variation at the histocompatibility loci A, B, and C. Results agree with previous findings based on smaller samples. Caucasian admixture of the Atacameños from Toconao was estimated to be 0.056 ± 0.022
ABO blood group system (1 work) · Antigen (1 work) · Biology (1 work) · Blood groups and transfusion (1 work) · Demography (1 work) · Genetics (1 work) · Genetics (1 work) · Histocompatibility (1 work) · Histocompatibility Testing (1 work) · Human leukocyte antigen (1 work)